miRagen Therapeutics
MGEN
#9422
Rank
A$0.13 B
Marketcap
A$33.39
Share price
-0.09%
Change (1 day)
N/A
Change (1 year)

Earnings for miRagen Therapeutics (MGEN)

Earnings in 2020 (TTM): -A$43.81 Million

According to miRagen Therapeutics's latest financial reports the company's current earnings are A$2.57 Million. In 2019 the company made an earning of -A$59.56 Million a decrease over its 2018 earnings that were of -A$46.19 Million.

Earnings history for miRagen Therapeutics from 2013 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-A$43.81 Million-26.43%
2019-A$59.56 Million28.93%
2018-A$46.19 Million21.82%
2017-A$37.92 Million107.72%
2016-A$18.26 Million12.44%
2015-A$16.24 Million62.91%
2014-A$9.97 Million3399.77%
2013-A$0.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ocular Therapeutix
OCUL
-A$0.39 Billion 798.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Oragenics
OGEN
-A$14.68 Million-65.82%๐Ÿ‡บ๐Ÿ‡ธ USA
OncoCyte
OCX
-A$84.47 Million 96.69%๐Ÿ‡บ๐Ÿ‡ธ USA